Table 1.
Sample Characteristics
| Characteristic | Total Sample N=1,799 |
Non-CVD Sample N=1,612 |
|---|---|---|
| Age, y | 66 ± 9 | 66 ± 9 |
| Female, % | 54 | 57 |
| Systolic blood pressure, mm Hg | 129 ± 17 | 128 ± 17 |
| Diastolic blood pressure, mm Hg | 74 ± 10 | 74 ± 10 |
| Body mass index, kg/m2 | 28 ± 5 | 28 ± 5 |
| Fasting glucose, mg/dL | 106 ± 23 | 106 ± 23 |
| Total cholesterol, mg/dL | 186 ± 37 | 189 ± 36 |
| LDL cholesterol, mg/dL | 105 ± 31 | 108 ± 31 |
| HDL cholesterol, mg/dL | 57 ± 18 | 58 ± 18 |
| Triglycerides, mg/dL | 119 ± 69 | 117 ± 68 |
| Hypertension, % | 63 | 60 |
| Diabetes mellitus, % | 13 | 11 |
| Cigarette smoking, % | 7 | 7 |
| Medications, % | ||
| ACE inhibitors | 24 | 22 |
| Angiotensin receptor blockers | 8 | 7 |
| Beta-blockers | 28 | 23 |
| Calcium channel blockers | 14 | 12 |
| Diuretics | 23 | 21 |
| Hormone replacement | 4 | 8 |
| Statins | 41 | 37 |
| Framingham risk score | 9 ± 4 | 9 ± 4 |
| Prevalent cardiovascular disease, % | 10 | — |
CVD, cardiovascular disease. Values shown are means ± standard deviation or percents.